Passage Bio, Inc. (PASG) Tops Q4 EPS by 2c

Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight